Clinical Trial Update: Longitudinal Neurocognitive, Psychosocial and Health-related Quality of Life Assessment in Advanced Cancer Survivors Treated With Immunotherapy and the Efficacy of Integrative Neurocognitive Remediation Therapy [NA]

View source ↗

Summary

A longitudinal study of advanced cancer survivors treated with immunotherapy assessing neurocognitive, psychosocial, and health-related quality of life outcomes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Cognitive Remediation, Neuropsychology | NA | Status: RECRUITING